The key to this research is the amino acid glutamine. Researchers have long believed that starving cancer cells of glutamine, which cancer cells require in larger quantities than normal cells, would help fight some cancers. Now, they have discovered a molecule that does the job: Dubbed 968 by investigators, this proof of concept molecule binds to the enzyme glutaminase to inhibit cancer growth by blocking the cancer cells’ utilization of glutamine.
Cancer cells demand a tremendous amount of energy, says Richard Cerione, the Goldwin Smith Professor of Pharmacology and Chemical biology. The finding could lead to a new class of drugs, capable of halting cancer progression without harming normal cell growth, he said.
After discovering that 968 inhibited glutaminase and effectively shrunk tumor cells, Cerione and his research team tested the molecule to understand its effects on non-cancerous cells.
“We have effectively stopped the growth of breast cancer cells in the lab without affecting normal mammary cells,” said Cerione, who is now investigating the impact of 968 on other forms of cancer, including prostate, ovarian and pancreatic cell lines. “We’ve validated our target. The next step will be to further the development of a classes of small molecules capable of stopping cancer cell growth in humans.” To that end, Cerione and colleagues are currently working with the KensaGroup, of Ithaca, N.Y., in addition to Cerione’s academic pursuits exploring the effects of 968 and glutaminase on cancer cell growth.
“Our research has highlighted a previously unrecognized connection between the cell’s metabolic machinery and the signaling pathways and growth factor receptors that regulate cell growth,” said Cerione. He believes there is a broader connection between metabolism and cell signaling for other areas in biology and biomedicine.
Cornell co-authors of the research include postdoctoral associate Jianbin Wang (co-first author), and senior research associates Jon Erickson (co-first author), Kristin Wilson and Sekar Ramachandran. Funding for the research: The National Institutes of Health and the Susan G. Komen Foundation.
Joe Schwartz | Newswise Science News
A Map of the Cell’s Power Station
18.08.2017 | Albert-Ludwigs-Universität Freiburg im Breisgau
On the way to developing a new active ingredient against chronic infections
18.08.2017 | Deutsches Zentrum für Infektionsforschung
Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.
As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...
Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.
Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...
For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.
While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...
An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.
The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...
A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.
Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences